The latest news from the global pharmaceutical industry. Below you will find news and information to keep you up-to-date with what is happening in your industry. Coverage includes regulatory approvals, recall announcements, mergers and acquisitions, personnel news and appointments, new facility and facility expansion updates, collaborations and agreements, and financial updates.
The FDA approved Rukobia, a new type of antiretroviral medication for adults living with HIV.
read more
ISA announced it received Orphan Drug Designation from the FDA in for ISA101b for treatment of HPV16-positive cervical cancer.
read more
Rhythm announced the FDA has granted rare pediatric disease designations for setmelanotide, an investigational MC4R agonist, for POMC deficiency ...
read more
Sandoz announced the US Court of Appeals has ruled against the company in patent litigation concerning the biosimilar Erelzi.
read more
Anivive announced the initiation of two pre-clinical studies to further evaluate the in vivo efficacy and safety of GC376 as a treatment for COVID-19.
read more
American Pharmaceutical Review has launched a new information resource to cover the development and manufacturing of the highest quality ...
read more
Novartis Pharma announced the Japanese Ministry of Health, Labour and Welfare approved five new treatment options for Japanese patients.
read more
Ardelyx announced the submission of an NDA for tenapanor to the FDA for the control of serum phosphorus in adult patients with chronic kidney disease ...
read more
The FDA took action to help facilitate the timely development of safe and effective vaccines to prevent COVID-19 by providing guidance with ...
read more
INOVIO announced positive interim clinical data of INO-4800, its vaccine candidate against novel coronavirus (SARS-CoV-2), from the first two Phase 1 ...
read more
The FDA approved KEYTRUDA for the first-line treatment of patients with unresectable or metastatic microsatellite instability-high or mismatch repair ...
read more
Carmine has signed a research collaboration agreement with Takeda to discover, develop and commercialize non-viral gene therapies for two rare disease...
read more
Croda International has agreed to acquire Avanti Polar Lipids, a company providing lipid-based drug delivery technologies for next generation ...
read more
Heron received CRL from the FDA regarding its NDA for HTX-011 for postoperative pain.
read more
RevImmune has launched the "ILIAD" Phase II trial for treatment of COVID-19.
read more